Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paraventricular Hypothalamic Nucleus | 14 | 2024 | 57 | 4.590 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 12 | 2023 | 152 | 3.110 |
Why?
|
| Hypertension | 13 | 2023 | 1398 | 2.990 |
Why?
|
| Excitatory Postsynaptic Potentials | 9 | 2025 | 130 | 1.880 |
Why?
|
| Neurons | 13 | 2024 | 2050 | 1.830 |
Why?
|
| Hypothalamus | 9 | 2023 | 223 | 1.670 |
Why?
|
| Receptors, AMPA | 2 | 2024 | 51 | 1.610 |
Why?
|
| Sympathetic Nervous System | 7 | 2023 | 67 | 1.310 |
Why?
|
| Calcineurin Inhibitors | 3 | 2024 | 31 | 1.230 |
Why?
|
| Tacrolimus | 3 | 2024 | 108 | 1.220 |
Why?
|
| Rats | 15 | 2024 | 3890 | 1.120 |
Why?
|
| Pituitary-Adrenal System | 2 | 2018 | 44 | 1.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2018 | 72 | 1.070 |
Why?
|
| Calcineurin | 2 | 2024 | 101 | 1.030 |
Why?
|
| Blood Pressure | 5 | 2023 | 1421 | 0.990 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2024 | 1310 | 0.990 |
Why?
|
| Calcium Channels, L-Type | 2 | 2021 | 54 | 0.860 |
Why?
|
| Rats, Inbred WKY | 8 | 2023 | 56 | 0.730 |
Why?
|
| Rats, Inbred SHR | 8 | 2023 | 67 | 0.730 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 133 | 0.680 |
Why?
|
| Stress, Psychological | 4 | 2021 | 603 | 0.660 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 47 | 0.650 |
Why?
|
| Glutamic Acid | 2 | 2020 | 209 | 0.650 |
Why?
|
| Presynaptic Terminals | 1 | 2020 | 83 | 0.650 |
Why?
|
| Orexin Receptors | 1 | 2019 | 2 | 0.640 |
Why?
|
| Vasomotor System | 1 | 2019 | 21 | 0.630 |
Why?
|
| Ion Channels | 1 | 2020 | 210 | 0.600 |
Why?
|
| KCNQ Potassium Channels | 1 | 2016 | 12 | 0.530 |
Why?
|
| Animals | 23 | 2025 | 36557 | 0.520 |
Why?
|
| Stress, Physiological | 1 | 2018 | 272 | 0.490 |
Why?
|
| Patch-Clamp Techniques | 4 | 2020 | 300 | 0.470 |
Why?
|
| Hippocampus | 2 | 2020 | 863 | 0.470 |
Why?
|
| Synapses | 3 | 2025 | 469 | 0.450 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 2018 | 59 | 0.430 |
Why?
|
| Calcium Channels | 3 | 2025 | 166 | 0.390 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1622 | 0.380 |
Why?
|
| Solute Carrier Family 12, Member 2 | 2 | 2023 | 7 | 0.350 |
Why?
|
| Obesity | 1 | 2019 | 2446 | 0.270 |
Why?
|
| Receptors, Kainic Acid | 1 | 2025 | 6 | 0.240 |
Why?
|
| Male | 17 | 2025 | 66127 | 0.230 |
Why?
|
| DNA Demethylation | 1 | 2023 | 10 | 0.220 |
Why?
|
| Psychomotor Performance | 1 | 2025 | 182 | 0.220 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2023 | 64 | 0.210 |
Why?
|
| Purkinje Cells | 1 | 2025 | 166 | 0.210 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 35 | 0.200 |
Why?
|
| Aspartic Acid | 1 | 2023 | 86 | 0.200 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 4 | 0.200 |
Why?
|
| Corticosterone | 3 | 2017 | 63 | 0.200 |
Why?
|
| Organ Culture Techniques | 2 | 2020 | 160 | 0.200 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 28 | 0.200 |
Why?
|
| Posterior Horn Cells | 1 | 2021 | 5 | 0.190 |
Why?
|
| Theta Rhythm | 1 | 2021 | 24 | 0.190 |
Why?
|
| Mice, Knockout | 4 | 2025 | 4016 | 0.170 |
Why?
|
| Nestin | 1 | 2020 | 19 | 0.170 |
Why?
|
| Microinjections | 1 | 2020 | 51 | 0.170 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 56 | 0.170 |
Why?
|
| Propionates | 1 | 2020 | 33 | 0.170 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 163 | 0.170 |
Why?
|
| Spinal Cord | 1 | 2021 | 276 | 0.160 |
Why?
|
| Orexins | 1 | 2019 | 8 | 0.160 |
Why?
|
| Telemetry | 1 | 2019 | 28 | 0.160 |
Why?
|
| Rats, Zucker | 1 | 2019 | 41 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 81 | 0.160 |
Why?
|
| Mice | 5 | 2025 | 19055 | 0.150 |
Why?
|
| Calcium | 1 | 2024 | 1148 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 288 | 0.150 |
Why?
|
| Pain | 1 | 2021 | 476 | 0.150 |
Why?
|
| Arterial Pressure | 1 | 2019 | 124 | 0.150 |
Why?
|
| Gene Silencing | 1 | 2019 | 247 | 0.150 |
Why?
|
| Hypoxia | 1 | 2020 | 268 | 0.150 |
Why?
|
| Peptides | 1 | 2022 | 863 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 567 | 0.140 |
Why?
|
| Adrenergic Fibers | 1 | 2017 | 4 | 0.140 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 104 | 0.140 |
Why?
|
| Receptors, GABA-B | 1 | 2017 | 12 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 34 | 0.140 |
Why?
|
| Receptors, Ghrelin | 1 | 2017 | 29 | 0.140 |
Why?
|
| Behavior, Animal | 1 | 2020 | 522 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2018 | 173 | 0.140 |
Why?
|
| Ghrelin | 1 | 2017 | 55 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4879 | 0.130 |
Why?
|
| Adenylate Kinase | 1 | 2016 | 13 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 721 | 0.130 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2016 | 19 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 720 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 174 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1740 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 2016 | 97 | 0.130 |
Why?
|
| Heart Rate | 1 | 2019 | 601 | 0.130 |
Why?
|
| Protein Subunits | 1 | 2016 | 174 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2018 | 278 | 0.120 |
Why?
|
| Casein Kinase I | 1 | 2015 | 12 | 0.120 |
Why?
|
| Glucose | 1 | 2020 | 927 | 0.120 |
Why?
|
| Neural Inhibition | 1 | 2016 | 110 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 174 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 738 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2018 | 717 | 0.100 |
Why?
|
| Brain | 1 | 2023 | 3224 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 1077 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3506 | 0.080 |
Why?
|
| Pregabalin | 1 | 2025 | 4 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2025 | 825 | 0.050 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2021 | 19 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 2021 | 63 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 452 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2021 | 129 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 599 | 0.040 |
Why?
|
| Female | 3 | 2021 | 71928 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 698 | 0.040 |
Why?
|
| Tetrazolium Salts | 1 | 2018 | 15 | 0.040 |
Why?
|
| Humans | 5 | 2025 | 134156 | 0.040 |
Why?
|
| DNA | 1 | 2023 | 1682 | 0.040 |
Why?
|
| Agouti-Related Protein | 1 | 2017 | 42 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 38 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2915 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 169 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 79 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2016 | 8 | 0.030 |
Why?
|
| Bumetanide | 1 | 2016 | 7 | 0.030 |
Why?
|
| Muscimol | 1 | 2016 | 9 | 0.030 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 32 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 59 | 0.030 |
Why?
|
| Pyridazines | 1 | 2016 | 54 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 318 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 395 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1140 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 915 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2198 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2539 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 4808 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 29399 | 0.010 |
Why?
|